These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 28939389)

  • 1. Recombinant allergen and peptide-based approaches for allergy prevention by oral tolerance.
    Campana R; Huang HJ; Freidl R; Linhart B; Vrtala S; Wekerle T; Karaulov A; Valenta R
    Semin Immunol; 2017 Apr; 30():67-80. PubMed ID: 28939389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope peptides and immunotherapy.
    Tanabe S
    Curr Protein Pept Sci; 2007 Feb; 8(1):109-18. PubMed ID: 17305564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant proteins and peptides as diagnostic and therapeutic reagents for arthropod allergies.
    Ramos JD; Valmonte GR; de Guia RM
    Protein Pept Lett; 2007; 14(10):992-1002. PubMed ID: 18220997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy.
    Valenta R; Vrtala S; Focke-Tejkl M; Bugajska-Schretter ; Ball T; Twardosz A; Spitzauer S; Grönlund H; Kraft D
    Biol Chem; 1999; 380(7-8):815-24. PubMed ID: 10494830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant allergy vaccines based on allergen-derived B cell epitopes.
    Valenta R; Campana R; Niederberger V
    Immunol Lett; 2017 Sep; 189():19-26. PubMed ID: 28472641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Therapy for Prophylactic Tolerance in Immunoglobulin E-mediated Allergy.
    Baranyi U; Farkas AM; Hock K; Mahr B; Linhart B; Gattringer M; Focke-Tejkl M; Petersen A; Wrba F; Rülicke T; Valenta R; Wekerle T
    EBioMedicine; 2016 May; 7():230-9. PubMed ID: 27322476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S; Deifl S; Bohle B
    Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?
    Tulaeva I; Kratzer B; Campana R; Curin M; van Hage M; Karsonova A; Riabova K; Karaulov A; Khaitov M; Pickl WF; Valenta R
    Front Immunol; 2020; 11():1368. PubMed ID: 32733455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant allergens for immunotherapy: state of the art.
    Zhernov Y; Curin M; Khaitov M; Karaulov A; Valenta R
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):402-414. PubMed ID: 31082821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects for peptide-based immunotherapy for dog allergy.
    Virtanen T
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):461-5. PubMed ID: 17088652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
    Focke M; Swoboda I; Marth K; Valenta R
    Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of specific immune responses by chemical and structural modifications of allergens.
    Akdis CA; Blaser K
    Int Arch Allergy Immunol; 2000 Apr; 121(4):261-9. PubMed ID: 10828716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Aspects of Allergens and Allergy.
    Valenta R; Karaulov A; Niederberger V; Gattinger P; van Hage M; Flicker S; Linhart B; Campana R; Focke-Tejkl M; Curin M; Eckl-Dorna J; Lupinek C; Resch-Marat Y; Vrtala S; Mittermann I; Garib V; Khaitov M; Valent P; Pickl WF
    Adv Immunol; 2018; 138():195-256. PubMed ID: 29731005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future.
    Valenta R; Campana R; Focke-Tejkl M; Niederberger V
    J Allergy Clin Immunol; 2016 Feb; 137(2):351-7. PubMed ID: 26853127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance.
    Berings M; Karaaslan C; Altunbulakli C; Gevaert P; Akdis M; Bachert C; Akdis CA
    J Allergy Clin Immunol; 2017 Nov; 140(5):1250-1267. PubMed ID: 28941667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide and Recombinant Allergen Vaccines for Food Allergy.
    Cook QS; Burks AW
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):162-171. PubMed ID: 29368278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Molecular Allergen Recognition Profile in China as Basis for Allergen-Specific Immunotherapy.
    D'souza N; Weber M; Sarzsinszky E; Vrtala S; Curin M; Schaar M; Garib V; Focke-Tejkl M; Li Y; Jones R; Chen H; Valenta R; Sun B
    Front Immunol; 2021; 12():719573. PubMed ID: 34512644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide and recombinant immunotherapy.
    Larché M
    Immunol Allergy Clin North Am; 2011 May; 31(2):377-89, xi. PubMed ID: 21530826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral tolerance and allergy.
    Hamad A; Burks W
    Semin Immunol; 2017 Apr; 30():28-35. PubMed ID: 28739336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.